Results for tag: "Laron Syndrome Drug"

The Laron Syndrome Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. It is composed of drugs used to treat Laron Syndrome, a rare genetic disorder that affects growth and development. These drugs are used to reduce the symptoms of the disorder, such as short stature, skeletal abnormalities, and impaired glucose tolerance. The drugs are typically administered orally or intravenously, depending on the severity of the disorder. The Laron Syndrome Drug market is a relatively small market, with only a few companies offering drugs for the treatment of the disorder. These companies include Novartis, Pfizer, and Sanofi, which all offer drugs for the treatment of Laron Syndrome. Other companies, such as Genentech and Merck, are also researching potential treatments for the disorder. Show Less Read more